Skip to content
GLP-1 Scorecard
Menu
Site position #107

Luci

Published by GLP-1 ScorecardUpdated

Luci is a budget-focused GLP-1 telehealth platform offering compounded medications with upfront pricing: compounded semaglutide as low as $99/month and compounded tirzepatide as low as $145/month, plus oral semaglutide and tirzepatide pill kits.

Visit LuciWe may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Semaglutide
$99/mo (starting dose, promotional rate, compounded)
Tirzepatide
$145/mo (starting dose, promotional rate, compounded)
Coverage
Coverage not published
Brand-name
Not confirmed

Weigh Luci against the full graded field on the best semaglutide providers scorecard, or line it up against its closest alternatives. If you are considering a compounded option, read about whether compounded semaglutide is legit and safe.

Factor breakdown

These are recorded editorial marks, not a measure of clinical outcomes. Current prices and policies may differ from those used in the marks. See the methodology.

Cost value84/100
Dose & formulation75/100
Clinical oversight71/100
Labs & monitoring53/100
Fulfillment70/100
Contract terms55/100

Strengths

  • Budget-friendly compounded GLP-1 pricing (compounded semaglutide as low as $99/month, tirzepatide as low as $145/month)
  • Multiple formats: compounded semaglutide and tirzepatide injections plus oral semaglutide and tirzepatide pill kits
  • Upfront pricing with no insurance required and a fast 3-minute questionnaire to start
  • Care delivered through DrTelx, an independent US telehealth medical group, with ongoing support and dose optimization
  • HIPAA-compliant platform with a large self-reported member base (50,000+)

What to consider

  • Compounded medications are not FDA-approved for weight loss (the site discloses this) — not brand Wegovy, Ozempic, Zepbound, or Mounjaro
  • Available only in select U.S. states, and the full state list is not published
  • The compounding pharmacy partner is not named
  • Headline prices are 'as low as' rates (asterisked) — your actual monthly cost may be higher
  • No LegitScript certification displayed; marketing leans heavily on testimonials

Bottom line — Grade C

Best for: Shoppers who want budget shoppers wanting low-cost compounded semaglutide or tirzepatide, including oral pill options.

Site position #107 of 541. Commercial relationships affect placement, not the score. See our featured provider, CoreAge Rx (#1), for comparison.

Closest here

The rankings grading nearest Luci — the realistic shortlist.

The 21 rankings nearest this one

View full scorecard rankings →

Pricing/verification reflect Luci's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on Luci's site. Not medical advice; see our disclosure.

← Back to the scorecard